Quantum Dot-Based Immunofluorescent Imaging of Ki67 and Identification of Prognostic Value in HER2-Positive (Non-Luminal) Breast Cancer [Erratum]

Sun J, Chen C, Jiang G, Tian W, Li Y, Sun S. Int J Nanomedicine. 2014;9(1):1339–1346.

An error during the preparation of Figure 3 for publishing led to the inadvertent creation of a duplicate region in figure part 3A on page 1342. The journal wishes to apologise for this error. The correct version of Figure 3 is shown below.

Figure 3 The different Ki67 expressions detected by QD-IHC (A and C) and IHC (B and D) in the same specimens. Abbreviations: IHC, immunohistochemistry; QD-IHC, quantum dot-immunohistochemistry. Notes: (A and B) are the same specimens; (C and D) are the same specimens. Scale bar: 25 μm.

Read the original article

© 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.